Literature DB >> 22026338

Undiagnosed hypertension and proteinuria in a market population in Ile-Ife, Nigeria.

Arogundade Fatiu1, Sanusi Abubakr, Hassan Muzamil, Gbadegesin Aderoju, Olarinoye Funmilayo, Otuyemi Bola, Akinsola Adewale.   

Abstract

INTRODUCTION: Hypertension and chronic kidney disease (CKD) are common in our urban and rural communities but the majority of affected individuals are not aware of their condition. We conducted free medical examination and screening during one of the market days in Odo-Ogbe market, Ile-Ife, Nigeria to evaluate the magnitude of undiagnosed hypertension and proteinuria.
METHODS: Participants were taken through a brief medical history and had their socio-demographic data taken. Weight and height were measured and body mass index (BMI) calculated. Blood pressure (BP) was measured using a mercury sphygmomanometer and urinalysis was done with the aid of dipstick test.
RESULTS: A total of 286 participants aged 13-90 years (Mean 49.5 ± 15.7 years) were screened. Females constituted 90.2% of the study population. One-hundred and eight (37.7%) of participants had hypertension and only 20 (6.7%) were previously diagnosed. Sixty-nine participants (24.1%) had stage-1 hypertension while 39 (13.6%) had stage-2 hypertension. Fifty-nine percent of participants had BMI above 25 kg/m2. Eighty five participants (29.7%) had proteinuria while only 13 (4.5%) had glycosuria. A significantly higher percentage of participants with stage-1 and stage-2 hypertension had proteinuria compared with non hypertensives. There was a positive correlation between age and BMI (r=0.171, P=0.004), age and systolic BP (r=0.378, P < 0.0001) as well as age and diastolic BP (r=0.197, P=0.001).
CONCLUSION: A high percentage of the studied population (31%) had undiagnosed hypertension and proteinuria (29.7%). Community screening for these disabling non communicable diseases and lifestyle modifications should be encouraged.

Entities:  

Mesh:

Year:  2011        PMID: 22026338     DOI: 10.4314/ajnt.v4i3.71026

Source DB:  PubMed          Journal:  Arab J Nephrol Transplant


  7 in total

1.  Patient-related barriers to hypertension control in a Nigerian population.

Authors:  Chimezie Godswill Okwuonu; Nnamdi Ezekiel Ojimadu; Enajite Ibiene Okaka; Fatai Momodu Akemokwe
Journal:  Int J Gen Med       Date:  2014-07-03

2.  Awareness level of kidney functions and diseases among adults in a Nigerian population.

Authors:  C G Okwuonu; I I Chukwuonye; S O Ogah; C Abali; O A Adejumo; E Oviasu
Journal:  Indian J Nephrol       Date:  2015 May-Jun

Review 3.  Prevalence and burden of chronic kidney disease among the general population and high-risk groups in Africa: a systematic review.

Authors:  Samar Abd ElHafeez; Davide Bolignano; Graziella D'Arrigo; Evangelia Dounousi; Giovanni Tripepi; Carmine Zoccali
Journal:  BMJ Open       Date:  2018-01-10       Impact factor: 2.692

4.  Frequency and associations of chronic kidney disease among gout patients from a University Teaching Hospital in Nigeria.

Authors:  Akpabio Akanimo Akpabio; Pam Stephen Dung-Gwom; Babatunde Hakeem Olaosebikan; Olufemi Oladipo Adelowo
Journal:  Reumatologia       Date:  2018-02-28

5.  Impaired renal function in a rural Ugandan population cohort.

Authors:  Robert Kalyesubula; Jeffrey P Hau; Gershim Asiki; Billy Ssebunya; Sylvia Kusemererwa; Janet Seeley; Liam Smeeth; Laurie Tomlinson; Robert Newton
Journal:  Wellcome Open Res       Date:  2019-05-20

6.  Prevalence and correlates of undiagnosed hypertension among staff of a Nigerian university community.

Authors:  Babangida Shehu Bappah; Aishat Shittu; Jibrin Sammani Usman; Jibril Mohammed Nuhu; Farida Garba Sumaila; Aisha Ahmad Ahmad; Jibril Mohammed
Journal:  Pan Afr Med J       Date:  2022-05-31

7.  A look at risk factors of proteinuria in subjects without impaired renal filtration function in a general population in Owerri, Nigeria.

Authors:  Ernest Ndukaife Anyabolu; Innocent Ijezie Chukwuonye; Arthur Ebelenna Anyabolu; Okezie Enwere
Journal:  Pan Afr Med J       Date:  2016-04-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.